Related Experiment Video
Updated: Apr 27, 2026

Tail Vein Transection Bleeding Model in Fully Anesthetized Hemophilia A Mice
Published on: September 30, 2021
[Acquired haemophilia A: two cases].
A de Vitry1, A Valois2, M Weinborn1
1Service de dermatologie, batiment Philippe-Canton, CHU, 6, rue du Morvan, 54500 Vandœuvre-lès-Nancy, France.
Acquired haemophilia A (AH) is a rare bleeding disorder characterized by spontaneous bleeds. Prompt diagnosis via prolonged activated partial thromboplastin time (aPTT) and factor VIII inhibitor screening is crucial for managing bleeding risks and associated conditions.
Area of Science:
- Hematology
- Immunology
- Oncology
Background:
- Acquired haemophilia A (AH) is a rare bleeding disorder.
- Presents with spontaneous subcutaneous bleeds.
- Diagnosis often relies on prolonged activated partial thromboplastin time (aPTT).
More Related Videos
Related Concept Videos
Disorders of Hemostasis
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Extrinsic and Intrinsic Pathways of Hemostasis
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemorrhagic Stroke ll: Pathophysiology
Introduction to Hemostasis
The three phases of hemostasis involve many clotting factors present in plasma and several substances released by platelets and injured tissue cells. It is a fast, localized,...
Hemorrhagic Stroke l: Introduction

